Narcolepsy: First-Ever Drug Targeting Condition Itself Approved by FDA
FDA Approves First Drug Targeting Narcolepsy Itself

The US Food and Drug Administration (FDA) has approved the first ever drug to treat narcolepsy itself, rather than just its symptoms. The approval marks a potential shift in how the sleep disorder is managed, moving beyond the management of individual symptoms to address the underlying condition.

The Scientific Breakthrough

Madeleine Finlay told Ian Sample how the scientific breakthrough came about. The development follows years of research into the mechanisms of narcolepsy, which has often been the butt of jokes and a comedic plot point, despite the serious reality of living with the condition.

Living with Narcolepsy

Julie Flygare, who has narcolepsy and founded the non-profit Project Sleep, explained what it is like to live with the condition. She described how the new drug could be a gamechanger for people with narcolepsy, offering hope for a more normal life.

The approval is seen as a significant step forward, potentially changing the landscape of treatment for those affected by the disorder.